Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Canakinumab for the treatment of autoinflammatory very early onset- inflammatory bowel disease.
Front Immunol. 2022 Sep 20;13:972114. doi: 10.3389/fimmu.2022.972114. eCollection 2022.
Front Immunol. 2022.
PMID: 36203564
Free PMC article.
Ruxolitinib: Targeted Approach for Treatment of Autoinflammatory Very Early Onset Inflammatory Bowel Disease.
Rudra S, Shaul E, Conrad M, Patel T, Moore A, Dawany N, Canavan MC, Sullivan KE, Behrens E, Kelsen JR.
Rudra S, et al. Among authors: canavan mc.
Clin Gastroenterol Hepatol. 2022 Jun;20(6):1408-1410.e2. doi: 10.1016/j.cgh.2021.07.040. Epub 2021 Jul 27.
Clin Gastroenterol Hepatol. 2022.
PMID: 34329777
Free PMC article.
Item in Clipboard
Cite
Cite